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Septic Arthritis as the First Sign of Candida tropicalis Fungaemia in an Acute
Lymphoid Leukemia Patient
Perla Vicari, Ronald Feitosa Pinheiro, Federal University of São Paulo, São Paulo, SP, Brazil
Maria de Lourdes Lopes Ferrari Chauffaille,
Mihoko Yamamoto and Maria Stella Figueiredo
Fungal infections caused by Candida species have increased in incidence during the past two
decades in England, North America and Europe. Candidal arthritis is rare in patients who are not
intravenous drug users or are who not using a prostheses. We report the case of a 24-year-old
man with acute lymphoid leukemia, who developed Candida tropicalis arthritis during an aplastic
period after chemotherapy. This is the eighth case described in the literature of C. tropicalis
causing arthritis without intra-articular inoculation. We call attention to an unusual first sign of
fungal infection: septic arthritis without intra-articular inoculation. However, this case differs
from the other seven, since despite therapy a fast and lethal evolution was observed. We reviewed
reported cases, incidence, risk factors, mortality and treatment of neutropenic patients with
fungal infections.
Key Words: Septic arthritis, Candida tropicalis, fungal infections, Candida tropicalis arthritis,
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During the past two decades, the incidence of fungal
infections has substantially increased in England, North
America and Europe. Several risk factors have been
found to be associated with these infections, including
the prolonged use of broad-spectrum antibiotics,
chemotherapy, hyperalimentation with fluids containing
high glucose concentrations, neutropenia and central
venous catheterization [1].
Systemic candidiasis is a common cause of septicemia,
but septic arthritis caused by Candida species is rare
[1,2]. Fungal arthritis has most commonly been caused
by C. albicans, although C. tropicalis  has been
reported, especially in granulocytopenic patients
[2,3,5,6]. We report an uncommon case of acute
monoarthritis caused by C. tropicalis, leading to systemic
candidiasis and death in a patient with acute lymphoid
leukemia during an aplastic period after chemotherapy.
Case Report
A 24-year-old white man with common acute
lymphoid leukemia (ALL) (CD10+, CD19+ and Igs), was
scheduled for systemic chemotherapy following the
GMALL protocol for ALL [3]. The chemotherapy was
administered via “port-a-cath” catheter, and during
treatment he developed Diabetes secondary to
corticosteroid therapy. Complete remission in the bone
marrow was achieved on the 28th day of the protocol.
On the 44th day, he had 0.9 X 109  leucocytes /L , and
G-CSF treatment was initiated. At the same time he
presented a painful left knee erythema, without fever.
Blood cultures were positive for methicillin-resistant
Staphylococcus aureus, and he was treated with
intravenous vancomycin.  After 5 days, despite G-CSF
use, the leucocyte count was 0.1 X 109  /L, he developed
fever and his knee became more painful and swollen.
Joint fluid aspiration showed yeast with optical
microscopy. Several blood and synovial fluid cultures
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Table 1. Review of reported cases of Candida tropicalis without intra-articular inoculation
Candida tropicalis Septic A
rthritis
Author/Date Age/Sex Underlying Risk factors Affected Treatment Follow up
disease joint
Murray et al. 77/M Bladder Leucopenia, central catheter, Shoulder AMB Arthritis
1976 [6] carcinoma BSA cured
Bayer et al. 12/ M ALL Chemotherapy, corticosteroid, Knee 5-flucytosine Disseminated
1978 [6] trauma AMB candidiasis and
death (21st day
of AMB therapy)
Fainstein et 59/M AML Leucopenia, chemotherapy, Knee AMB Arthritis cured
al. 1982 [6] corticosteroid, BSA miconazole
Fainstein et 67/M CML Chemotherapy leucopenia, Knee Ketoconazole Arthritis cured
al. 1984 [6] BSA
Mandel et 66/ W LL BSA, chemotherapy Knee AMB Arthritis cured
al. 1984 [3] miconazole
Weisse et al. 1 month/ Prematurity BSA, hyperalimentation fluids Knee AMB, Arthritis cured
1993 [6] M 5-flucytosine
Pothoff et al. 77/W AML Leucopenia, chemotherapy, Knee Fluconazole Arthritis cured
1997 [6] central catheter
Present  case 24/M ALL Leucopenia, Diabetes, central Knee AMB Disseminated
catheter, BSA, chemotherapy, candidiasis and
corticosteroid death (9th  day of
AMB therapy)
ALL= acute lymphocytic leukaemia; AML= acute myeloid leukaemia; CML= chronic myelocytic leukaemia; LL= lymphocytic lymphoma; AMB= amphotericin B;
BSA= broad-spectrum antibiotics.
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were positive for C. tropicalis. Treatment with
intravenous amphotericin B at a dosage of 1 mg/Kg daily
was started, and six hours later he developed skin lesions,
identified as candidal embolic skin  lesions by biopsy.
The patient evolved to hypotension and signs of septic
shock. Nine days after the monoarthritis began, he died
due to septic shock, secondary to fungaemia.
Discussion
Systemic candidiasis is a common cause of
septicemia, but septic arthritis caused by Candida
species is rare [1,2]. Dissemination to the joint is most
frequently provoked by intra-articular inoculation,
including injection, surgery and prosthesis; or by
hematogenous dissemination, usually in intravenous
drug abusers [4,5]. Most of the cases of candidiasis
described in the literature caused by C. albicans
(60%) and C. tropicalis (18%) have been reported
secondarily, especially in granulocytopenic patients [5].
We report the eighth known case of the arthritis
caused by C. tropicalis without intra-articular
inoculation (Table 1) [4,6]. The mortality associated
with candidemia in hospitalized patients with cancer is
60%, and without cancer it is 38% [5]. A multivariate
analysis for mortality rates associated with candidemia
etiology  indicated a significantly better survival rate
for C. albicans. Furthermore, in animal and human
studies C. tropicalis has also been found to be
intrinsically more virulent than C. albicans [5]. The
increasing use of potent antibiotics,
immunosuppressives, parenteral nutrition, and
corticosteroids, as well as the presence of neutropenia,
central venous catheters, traumatized skin, diabetes,
and joint prosthesis are predisposing factors for fungal
infection [1,2]. Fungaemia in patients on chemotherapy
may be attributable to the absence of fluconazole
prophylaxis.(1) However, this type of prophylaxis has
resulted in a rise in the proportion of hematogenous
candidiasis caused by C. glabrata and C. krusei [5].
Our patient presented several of the clinical
pathological features identified by Leung et al., including
neutropenia, central venous catheter use, and treatment
with broad-spectrum antibiotics, as well as diabetes
secondary to corticosteroid therapy, which is a known
predisposing factor for fungal infection [1].
The standard recommendation for patients with
candidemia or deep candidal infection is administration
of amphotericin B. Generally 800 mg daily of
fluconazole or > 0.7 mg/kg daily of amphotericin B is
given. However, fluconazole has been associated with
a 15% failure rate. The treatment should be continued
for more than two weeks after the last positive blood
culture results, and resolution of all clinical
manifestations of candidal infection [5].
Conclusion
We call attention to an unusual first sign of fungal
infection, septic arthritis without intra-articular
inoculation. However, this case differs from the seven
other known cases, since despite therapy a fast and
lethal evolution was observed. We emphasize that the
most important factors for the successful treatment of
fungal arthritis are early diagnosis and prompt therapy.
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